Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

8 Best Fast Growing Penny Stocks to Buy Right Now

Page 1 of 2

In this article, we will discuss the 8 Best Fast Growing Penny Stocks to Buy Right Now.

On May 4, Gregory Daco, EY-Parthenon Chief Economist, joined CNBC’s ‘Squawk Box’ to discuss the current state of the US economy and the Fed’s likely trajectory. He described an environment characterized by high nominal growth that is increasingly driven by inflation rather than real growth. While GDP remains relatively strong, Daco argued that the breadth of this growth is dangerously narrow, resting on three specific pillars: affluent consumers, AI investment, and asset price appreciation through stock market gains. He warned that while these pillars can create a virtuous cycle, they are vulnerable to shocks from geopolitical conflicts or doubts regarding AI returns.

Daco elaborated on the overlap between these growth pillars and noted that stock market wealth significantly fuels consumer spending. However, he highlighted a growing fragility beneath the surface. While higher-income families continue to spend freely, lower and median-income families are struggling with high prices. Data from a recent Friday shows that real disposable income grew at only 0.4% year-over-year, while consumer spending advanced at 2%. This discrepancy is further emphasized by the fact that real disposable income has been negative for two of the last three months and three of the last four.

Our Methodology

We used the Finviz Screener to identify stocks trading between $1 and $5 a share and focused on companies that have generated more than 100% sales growth over the past year and 50% growth over the past three years. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q4 2025.

Note: All data was sourced on May 7. 

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

8 Best Fast Growing Penny Stocks to Buy Right Now

8. Gevo Inc. (NASDAQ:GEVO)

Number of Hedge Fund Holders: 10

Gevo Inc. (NASDAQ:GEVO) is one of the best fast growing penny stocks to buy right now. On April 15, Gevo announced its withdrawal from the US Department of Energy’s loan guarantee process for its Alcohol-to-Jet (or ATJ)-30 plant. The decision followed a determination that the department’s requirement to support enhanced oil recovery is not currently commercially viable in the project area. By withdrawing, Gevo aims to pursue alternative financing that better aligns with its corporate strategy and provides improved returns while accelerating the timeline for project execution.

The company plans to continue developing the ATJ-30 project at its recently acquired North Dakota facility, which already features low-carbon ethanol production and carbon sequestration capabilities. Management noted that this site is cash-generating and serves as a strategic foundation for expanding sustainable aviation fuel/SAF production. Gevo Inc. (NASDAQ:GEVO) had previously worked with the Department of Energy on a conditional commitment for a South Dakota project, but is now shifting its focus to this more integrated location.

Despite the change in financing direction, Gevo remains committed to securing funding for the plant by the end of 2026. The company believes that its efforts over the past year have significantly reduced risk in its low-carbon ethanol supply chain, putting it in a stronger position to attract private capital. CEO Paul Bloom emphasized that the North Dakota facility’s existing economic foundation will support the company’s broader franchise development strategy for renewable fuels and chemicals.

Gevo Inc. (NASDAQ:GEVO) works on abating carbon, providing different kinds of fuel, specific items for the food chain, hydrocarbons for gasoline, and plastic material. It is also engaged in the development, construction, and operation of Alcohol-to-Jet initiatives.

7. TriSalus Life Sciences Inc. (NASDAQ:TLSI)

Number of Hedge Fund Holders: 10

TriSalus Life Sciences Inc. (NASDAQ:TLSI) is one of the best fast growing penny stocks to buy right now. On May 4, TriSalus Life Sciences initiated patient enrollment for the PREDICTT clinical trial, a prospective study evaluating its proprietary Pressure-Enabled Drug Delivery/PEDD technology in patients with primary or metastatic liver tumors. Conducted at The University of Texas MD Anderson Cancer Center, the study uses the TriNav Infusion System to deliver Y90 radioembolization therapy.

The goal is to determine if this pressure-enabled approach can enhance tumor targeting and improve the distribution of radiation doses compared to traditional methods. The investigator-led trial will enroll approximately 20 adult patients with unresectable tumors to analyze how the TriNav system affects tumor-to-normal liver enhancement ratios. Researchers will use CT and SPECT/CT imaging to correlate these measurements with actual microsphere distribution and overall treatment outcomes.

This focus on precision delivery aims to maximize the therapeutic dose to the tumor while minimizing exposure to healthy surrounding liver tissue. The collaboration with MD Anderson represents an effort to generate clinical evidence that could redefine the standard of care for liver-directed therapies. By assessing the safety and efficacy of the TriNav system in conjunction with Y90, TriSalus seeks to address the long-standing challenge of optimizing drug delivery in solid tumors.

TriSalus Life Sciences Inc. (NASDAQ:TLSI) develops drug delivery technology platforms and immuno-oncology therapeutics aimed at improving outcomes for patients with difficult-to-treat liver and pancreatic cancers in the US.

Page 1 of 2

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.